BETHESDA, Md.--(BUSINESS WIRE)--Feb. 15, 2006--RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN) announced today that Dr. L. Thompson Bowles joined the company’s Board of Directors, effective immediately and for a term expiring at the next annual meeting.
